Javascript must be enabled to continue!
Solubility-aware protein binding peptide design using AlphaFold
View through CrossRef
AbstractNew protein–protein interactions (PPIs) are being identified, but PPIs have different physicochemical properties compared with conventional targets, making it difficult to use small molecules. Peptides offer a new modality to target PPIs, but designing appropriate peptide sequences by computation is challenging. Recently, AlphaFold and RosettaFold have made it possible to predict protein structures from amino acid sequences with ultra-high accuracy, enabling de novo protein design. We designed peptides likely to have PPI as the target protein using the “binder hallucination” protocol of AfDesign, a de novo protein design method using AlphaFold. However, the solubility of the peptides tended to be low. Therefore, we designed a solubility loss function using solubility indices for amino acids and developed a solubility-aware AfDesign binder hallucination protocol. The peptide solubility in sequences designed using the new protocol increased with the weight of the solubility loss function; moreover, they captured the characteristics of the solubility indices. Moreover, the new protocol sequences tended to have higher affinity than random or single residue substitution sequences when evaluated by docking binding affinity. Our approach shows that it is possible to design peptide sequences that can bind to the interface of PPI while controlling solubility.
Title: Solubility-aware protein binding peptide design using AlphaFold
Description:
AbstractNew protein–protein interactions (PPIs) are being identified, but PPIs have different physicochemical properties compared with conventional targets, making it difficult to use small molecules.
Peptides offer a new modality to target PPIs, but designing appropriate peptide sequences by computation is challenging.
Recently, AlphaFold and RosettaFold have made it possible to predict protein structures from amino acid sequences with ultra-high accuracy, enabling de novo protein design.
We designed peptides likely to have PPI as the target protein using the “binder hallucination” protocol of AfDesign, a de novo protein design method using AlphaFold.
However, the solubility of the peptides tended to be low.
Therefore, we designed a solubility loss function using solubility indices for amino acids and developed a solubility-aware AfDesign binder hallucination protocol.
The peptide solubility in sequences designed using the new protocol increased with the weight of the solubility loss function; moreover, they captured the characteristics of the solubility indices.
Moreover, the new protocol sequences tended to have higher affinity than random or single residue substitution sequences when evaluated by docking binding affinity.
Our approach shows that it is possible to design peptide sequences that can bind to the interface of PPI while controlling solubility.
Related Results
Design of Cyclic Peptides Targeting Protein-Protein Interactions using AlphaFold
Design of Cyclic Peptides Targeting Protein-Protein Interactions using AlphaFold
AbstractMore than 930,000 protein-protein interactions (PPIs) have been identified in recent years, but their physicochemical properties differ from conventional drug targets, comp...
Assessment of AlphaFold structures and optimization methods for virtual screening
Assessment of AlphaFold structures and optimization methods for virtual screening
AbstractRecent advancements in artificial intelligence such as AlphaFold, have enabled more accurate prediction of protein three-dimensional structure from amino acid sequences. Th...
Applications of AlphaFold beyond Protein Structure Prediction
Applications of AlphaFold beyond Protein Structure Prediction
AbstractPredicting structures accurately for natural protein sequences by DeepMind’s AlphaFold is certainly one of the greatest breakthroughs in biology in the twenty-first century...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Anemia Is Inversely Associated with Serum C-Peptide Concentrations in Patients with Type 2 Diabetes
Anemia Is Inversely Associated with Serum C-Peptide Concentrations in Patients with Type 2 Diabetes
Results: The aim of the study was to investigate the relationship between anemia and serum C-peptide concentrations in Korean patients with type 2 diabetes. A total of 1,300 subjec...
Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
The human papillomavirus E7 gene can transform murine fibroblasts and cooperate with other viral oncogenes in transforming primary cell cultures. One biochemical property associate...
Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor
Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor
ABSTRACT
The islets of Langerhans contain four distinct endocrine cell types producing the hormones glucagon, insulin, somatostatin and pancreatic polypeptide. These...

